Press Releases

Roslin Cells To Manufacture iPS Cells For Bipolar Disorder Research

2012-03-05T13:56:40Z

Edinburgh, Scotland – 05 March 2012: Roslin Cells Ltd, announced today that it will be participating in a consortium to generate human induced pluripotent stem cells (iPS cells) to study bipolar affective disorder...

Roslin Cells Relocates to the Scottish Centre for Regenerative Medicine

2011-11-23T09:00:00Z

Edinburgh, Scotland – 23 November 2011: Roslin Cells Ltd., world leaders in the isolation of new clinical grade pluripotent stem cells, announced today that it has now moved to the new Scottish Centre for Regenerative Medicine at Edinburgh BioQuarter.

Pfizer and Roslin Cells Pluripotent Stem Cell Evaluation Agreement

2011-07-13T08:00:00Z

Pluripotent Stem Cell Evaluation Agreement between Roslin Cells and Pfizer for regenerative medicine development.

UK, July 2011 – Roslin Cells and Pfizer Limited have signed an agreement for Pfizer to evaluate Roslin’s GMP quality Pluripotent Stem Cells (PSC).

Roslin Cells and Advanced Cell Technology Announce Collaboration

2011-06-21T08:00:00Z

Roslin Cells and Advanced Cell Technology announce collaboration to produce clinical grade human embryonic stem cell lines.

Edinburgh, Scotland – 21 June 2011: Roslin Cells Ltd., world leaders in the isolation of new clinical grade undifferentiated stem cells, and Advanced Cell Technology, Inc. (ACT), one of the leading US companies in regenerative medicine, announced that they have entered into a collaboration agreement to establish new clinical grade human embryonic stem cell (hESC) lines using ACTs patented, proprietary “single-cell blastomere” technique.

Roslin Cells Retains ISO 9001 Certification

2011-06-06T08:00:00Z

Roslin Cells retains certification to the internationally recognised quality management system standard, ISO 9001

Edinburgh, Scotland – 06 June 2011: Roslin Cells Ltd., world leaders in the isolation of new clinical grade undifferentiated stem cells, announced today that is has successfully retained certification to ISO 9001, the internationally recognised management system standard which serves as a benchmark for quality management systems.

Leaders Sign Ground-Breaking Deal On Stem Cell Standardisation

2011-05-10T08:00:00Z

Sistemic Ltd and Roslin Cells Ltd.

London, 10^th May 2011: Sistemic Ltd and Roslin Cells Ltd today signed a Memorandum of Understanding to promote the development of new technologies for the standardisation of the manufacture of stem cells for their use in cell therapy and drug development screening.

Roslin Cells Scoops the Mid and East Lothian Chamber of Commerce High Growth Award 2010

2010-12-13T09:00:00Z

Edinburgh, UK, 13 December 2010 – On November 18 Roslin Cells Ltd. won the Midlothian and East Lothian Chamber of Commerce High Growth Award for 2010. The award, sponsored by the accountancy group Springfords, goes to businesses who demonstrate investment in future development that substantially improves their performance or potential growth.

Roslin Cells Announces the Roslin Cell Therapy Partner Program

2010-10-04T08:00:00Z

Edinburgh, UK, 04 October 2010 – Roslin Cells Ltd., a leading provider of clinical grade pluripotent stem cells, announced today the Roslin Cell Therapy Partner Program. This innovative program will assist researchers in commercial and academic organisations with world leading expertise in the biology of cells of a particular type to translate their research into cell therapies which could be applied in the regenerative medicine field.

Roslin Cells Announces Collaboration with Lonza for Pluripotent Stem Cell Media Development

2010-08-05T08:00:00Z

Edinburgh, UK, 05 August 2010 – Roslin Cells Ltd. has entered a worldwide, in kind research collaboration agreement with Lonza, Walkersville, Inc. (US) for the development of customized cell culture media and processes for the production of pluripotent stem cells (PSCs) to advance the field of cell therapy.